Global Biodefense Market, By Vaccine Type (Botulism, Anthrax, Radiation/Nuclear, Smallpox, Others), Biothreat Detection Device (Samplers, Assays, Identifiers, Detectors/Triggering Devices, Others), End-Users (Hospital, Military, Ambulatory Care Centers, Research Organizations, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Biodefense Market
Biodefense market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.90% in the above mentioned forecast period.
Biodefense is the activity of preparing for, responding to and countering the acts of bioterrorism. A bioterrorism attack involves the deliberate release of viruses, bacteria and other pathogens which can cause chronic illness to humans, animals and environment. Biodefense includes different medical measures which are followed to protect individuals against biological threats such as administering medicinal drugs and vaccinations. It also includes medical research and preparations to defend against bioterrorism attacks.
Rise in the number of naturally occurring outbreaks, presence of favourable government initiatives, rising importance for disease surveillance mission to combat bioterrorism, growing focus of public health services for the development of test and procedures for the identification of biothreat agents, increasing threat of biological weapons and nuclear armed ICBM and growing threat of terrorism are the factors that will expand the biodefense market.
Rise in the research and development activities and increased adoption of technologies will provide beneficial opportunities for the biodefense market in the forecast period of 2021-2028.
However, low funding by the government for R&D activities in the developing and underdeveloped economies and stringent regulatory policies are the factors that will hinder the market growth and will further challenge the biodefense market in the forecast period mentioned above.
This biodefense market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biodefense market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Biodefense Market Scope and Market Size
The biodefense market is segmented on the basis of vaccine type, biothreat detection device, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of vaccine type, the biodefense market is segmented into botulism, anthrax, radiation/nuclear, smallpox and others.
- On the basis of biothreat detection device, the biodefense market is segmented into samplers, assays, identifiers, detectors/triggering devices and others.
- On the basis of end-users, the biodefense market is segmented into hospital, military, ambulatory care centers, research organizations and others.
The biodefense market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Biodefense Market Country Level Analysis
Biodefense market is analyzed and market size information is provided by the country, vaccine type, biothreat detection device, end-users and distribution channel as referenced above.
The countries covered in the biodefense market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the biodefense market due to the presence of major key players, enhanced lab capabilities and well-developed infrastructure for raising alarm for the threat to health in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the upsurge in the adoption of precise analytical instruments and rapid advancement of the biotechnology industry.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Biodefense market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Biodefense Market Share Analysis
Biodefense market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to biodefense market research.
The major players covered in the biodefense market report are Bavarian Nordic, Alnylam Pharmaceuticals, Inc., SIGA Technologies, Emergent BioSolutions Inc., Cleveland Bio Labs, Dynavax Technologies, Elusys Therapeutics, Inc., Soligenix, Pluristem Therapeutics Inc., Altimmune, General Dynamics Information Technology, Inc., Ichor Medical Systems, Ology Bioservices, Arbutus Biopharma, GlaxoSmithKline plc, Sanofi, XOMA Corporation, HyTest Ltd., ANP Technologies, Inc., Alexeter Technologies LLC, and Profectus BioSciences Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-